/
BKHA
$11.91-$0.23 (-1.89%)prev close
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$49.5M
4M shares
52-week range
$10.61 – $13.09
52% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NASDAQ
CS
Borrow rate
1.22%
Moderate
Price (6 mo)
Loading chart…
Change+$1.78
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 |
| Gross margin | — | — | — |
| R&D | $0 | $0 | $0 |
| Operating income | −$113 | −$576.1K | −$915.5K |
| EBITDA | −$18.7K | −$576.1K | −$915.5K |
| Net income | −$113 | $1.9M | $1.3M |
| Net margin | — | — | — |
| EPS (diluted) | -0.00 | 0.21 | 0.19 |
Annual figures · source: Financial Modeling Prep
Peer comparison
Black Hawk Acquisition Corporation Class A Ordinary Shares
Black Hawk Acquisition Corp is a Blank check company.
www.bhspac.com- IPO / List date
- May 13, 2024
- HQ
- DANVILLE, CA
Held by traders on TradeandTell
No one on the platform currently holds BKHA.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BKHA as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BKHA yet.
